CD14 and cancer: Additional studies showed that human CD14− ncM were the most inflammatory of the subsets, and an increase in ncM was associated with autoimmune disorders and promotion of Th1-type responses, whereas CD14+ cM and intM have been found to attenuate T cell responses and were associated with certain diseases in humans such as sepsis and certain cancers [18, 19].